RESPNet Flu, RSV, Covid Test Codes
This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc. Current Procedural Terminology (CPT) is copyright 2020 American Medical Association. All rights reserved.
Influenza virus A & B & Respiratory syncytial virus RNA panel
Influenza virus A & Influenza virus B & SARS coronavirus 2 & Respiratory syncytial virus RNA panel
Influenza virus A & Influenza virus B & SARS coronavirus+SARS coronavirus 2 Ag panel
Influenza virus A & Influenza virus B & SARS coronavirus 2 Ag panel
Influenza virus A & Influenza virus B & SARS coronavirus 2 & SARS-related coronavirus RNA panel
Influenza virus A & Influenza virus B & SARS coronavirus 2 identified
Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel
Deprecated Influenza virus A Ab [Presence] in Serum
Deprecated Influenza virus A Ab [Titer] in Serum
Deprecated Influenza virus A Ab [Units/volume] in Serum
Deprecated Influenza virus A hemagglutinin H5 RNA [Presence] in Unspecified specimen by Probe & target amplification method
Deprecated Influenza virus A neuraminidase cDNA [Presence] in Isolate by Amplification/Sequencing
Deprecated Influenza virus A RNA [Presence] in Unspecified specimen by Probe & target amplification method
Influenza virus A [Presence] in specimen by Organism specific culture
Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance [Susceptibility] in Unspecified specimen by Genotype method
Influenza virus A Ab [Identifier] in Serum
Influenza virus A Ab [Identifier] in Serum by Neutralization test
Influenza virus A Ab [Presence] in Body fluid
Influenza virus A Ab [Presence] in Cerebral spinal fluid
Influenza virus A Ab [Presence] in Serum
Influenza virus A Ab [Presence] in Serum --1st specimen
Influenza virus A Ab [Presence] in Serum --2nd specimen
Influenza virus A Ab [Presence] in Serum by Complement fixation
Influenza virus A Ab [Presence] in Serum by Hemagglutination inhibition
Influenza virus A Ab [Presence] in Serum by Immune diffusion (ID)
Influenza virus A Ab [Presence] in Serum by Immunoassay
Influenza virus A Ab [Titer] in Cerebral spinal fluid
Influenza virus A Ab [Titer] in Serum --1st specimen
Influenza virus A Ab [Titer] in Serum --2nd specimen
Influenza virus A Ab [Titer] in Serum by Agglutination
Influenza virus A Ab [Titer] in Serum by Complement fixation
Influenza virus A Ab [Titer] in Serum by Complement fixation --1st specimen
Influenza virus A Ab [Titer] in Serum by Complement fixation --2nd specimen
Influenza virus A Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A Ab [Units/volume] in Cerebral spinal fluid
Influenza virus A Ab [Units/volume] in Serum
Influenza virus A Ab [Units/volume] in Serum by Complement fixation
Influenza virus A Ab [Units/volume] in Serum by Immunoassay
Influenza virus A Ab [Units/volume] in specimen
Influenza virus A Ab/Positive control in Serum by Immunoassay
Influenza virus A Ag [Identifier] in Isolate
Influenza virus A Ag [Presence] in Bronchial specimen
Influenza virus A Ag [Presence] in Bronchial specimen by Immunofluorescence
Influenza virus A Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence
Influenza virus A Ag [Presence] in Isolate by Immunofluorescence
Influenza virus A Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Influenza virus A Ag [Presence] in Nasopharynx
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
Influenza virus A Ag [Presence] in Nasopharynx by Immunofluorescence
Influenza virus A Ag [Presence] in Nasopharynx by Rapid immunoassay
Influenza virus A Ag [Presence] in Nose by Immunoassay
Influenza virus A Ag [Presence] in Nose by Immunofluorescence
Influenza virus A Ag [Presence] in Throat
Influenza virus A Ag [Presence] in Throat by Immunoassay
Influenza virus A Ag [Presence] in Throat by Immunofluorescence
Influenza virus A Ag [Presence] in Tissue by Immunofluorescence
Influenza virus A Ag [Presence] in Trachea by Immunofluorescence
Influenza virus A Ag [Presence] in specimen
Influenza virus A Ag [Presence] in specimen by Immune diffusion (ID)
Influenza virus A Ag [Presence] in specimen by Immunoassay
Influenza virus A Ag [Presence] in specimen by Immunofluorescence
Influenza virus A and B Ab [Interpretation] in Body fluid
Influenza virus A and B Ag [Identifier] in Nose by Immunofluorescence
Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay
Influenza virus A and B Ag [Identifier] in specimen by Immunofluorescence
Influenza virus A and B Ag [Identifier] in specimen by Rapid immunoassay
Influenza virus A and B Ag panel – Upper Respiratory specimen by Rapid immunoassay
Influenza virus A and B and H1 2009 pandemic RNA [Identifier] in Upper respiratory specimen by NAA with probe detection
Influenza virus A and B identified in Nasopharynx by Shell vial culture
Influenza virus A and B identified in specimen by Bioassay
Influenza virus A and B RNA [Identifier] in Isolate by NAA with probe detection
Influenza virus A and B RNA [Identifier] in specimen by NAA with probe detection
Influenza virus A Bangkok Ab [Titer] in Cerebral spinal fluid
Influenza virus A Bangkok Ab [Units/volume] in Serum
Influenza virus A Bangkok Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A cDNA [Presence] in specimen by NAA with probe detection
Influenza virus A England Ab [Units/volume] in Serum
Influenza virus A England Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A H1 2009 pandemic Ab [Titer] in Serum
Influenza virus A H1 2009 pandemic and Influenza virus A swine origin RNA [Interpretation] in specimen Qualitative by NAA with probe detection
Influenza virus A H1 2009 pandemic RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
Influenza virus A H1 2009 pandemic RNA [Cycle Threshold #] in specimen by NAA with probe detection
Influenza virus A H1 2009 pandemic RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with non-probe detection
Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with probe detection
Influenza virus A H1 2009 pandemic RNA [Presence] in specimen by NAA with probe detection
Influenza virus A H1 2009 pandemic RNA panel - specimen by NAA with probe detection
Influenza virus A H1 Ab [Titer] in Serum
Influenza virus A H1 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H1 Ag [Presence] in Isolate by Immunofluorescence
Influenza virus A H1 Ag [Titer] in Isolate by Hemagglutination inhibition
Influenza virus A H1 HA gene [Presence] in Nasopharynx by NAA with probe detection
Influenza virus A H1 RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
Influenza virus A H1 RNA [Presence] in Isolate by NAA with probe detection
Influenza virus A H1 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with non-probe detection
Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with probe detection
Influenza virus A H1 RNA [Presence] in Unspecified specimen by NAA with probe detection
Influenza virus A H1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Influenza virus A H1.neuraminidase inhibitor resistance [Susceptibility] in specimen by Genotype method
Influenza virus A H1+H3+B RNA [Presence] in specimen by NAA with probe detection
Influenza virus A H10 Ab [Titer] in Serum
Influenza virus A H10 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H11 Ab [Titer] in Serum
Influenza virus A H11 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H12 Ab [Titer] in Serum
Influenza virus A H12 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H13 Ab [Titer] in Serum
Influenza virus A H13 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H14 Ab [Titer] in Serum
Influenza virus A H14 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H15 Ab [Titer] in Serum
Influenza virus A H15 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H16 Ab [Titer] in Serum
Influenza virus A H16 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H2 Ab [Titer] in Serum
Influenza virus A H2 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H2 RNA [Presence] in Unspecified specimen by NAA with probe detection
Influenza virus A H3 Ab [Titer] in Serum
Influenza virus A H3 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H3 Ag [Presence] in Isolate by Immunofluorescence
Influenza virus A H3 Ag [Titer] in Isolate by Hemagglutination inhibition
Influenza virus A H3 HA gene [Presence] in Nasopharynx by NAA with probe detection
Influenza virus A H3 RNA [Cycle Threshold #] in specimen by NAA with probe detection
Influenza virus A H3 RNA [Presence] in Isolate by NAA with probe detection
Influenza virus A H3 RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with non-probe detection
Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with probe detection
Influenza virus A H3 RNA [Presence] in specimen by NAA with probe detection
Influenza virus A H3 RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Influenza virus A H4 Ab [Titer] in Serum
Influenza virus A H4 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H5 Ab [Presence] in Serum
Influenza virus A H5 Ab [Titer] in Serum
Influenza virus A H5 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H5 Ag [Titer] in Isolate by Hemagglutination inhibition
Influenza virus A H5 Asian RNA [Cycle Threshold #] in Respiratory specimen by Nucleic acid amplification using primer-probe set H5a
Influenza virus A H5 Asian RNA [Cycle Threshold #] in Respiratory specimen by Nucleic acid amplification using primer-probe set H5b
Influenza virus A H5 Asian RNA [Presence] in specimen by NAA with probe detection
Influenza virus A H5 icA RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection
Influenza virus A H5 RNA [Presence] in Isolate by NAA with probe detection
Influenza virus A H5 RNA [Presence] in specimen by NAA with probe detection
Influenza virus A H5 RNA [Units/volume] (viral load) in specimen by NAA with probe detection
Influenza virus A H5a RNA [Presence] in specimen by NAA with probe detection
Influenza virus A H5b RNA [Presence] in specimen by NAA with probe detection
Influenza virus A H6 Ab [Titer] in Serum
Influenza virus A H6 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H6 RNA [Presence] in specimen by NAA with probe detection
Influenza virus A H6 RNA [Units/volume] (viral load) in specimen by NAA with probe detection
Influenza virus A H7 Ab [Titer] in Serum
Influenza virus A H7 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H7 Ag [Titer] in Isolate by Hemagglutination inhibition
Influenza virus A H7 Eurasia RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
Influenza virus A H7 Eurasia RNA [Presence] in Respiratory specimen by NAA with probe detection
Influenza virus A H7 RNA [Presence] in Isolate by NAA with probe detection
Influenza virus A H7 RNA [Presence] in Unspecified specimen by NAA with probe detection
Influenza virus A H7 RNA [Units/volume] (viral load) in specimen by NAA with probe detection
Influenza virus A H8 Ab [Titer] in Serum
Influenza virus A H8 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H9 Ab [Titer] in Serum
Influenza virus A H9 Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus A H9 RNA [Presence] in Isolate by NAA with probe detection
Influenza virus A H9 RNA [Presence] in Unspecified specimen by NAA with probe detection
Influenza virus A HA gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A hemagglutinin cDNA [Identifier] in Isolate by NAA with probe detection
Influenza virus A hemagglutinin cDNA [Identifier] in specimen by NAA with probe detection
Influenza virus A hemagglutinin cDNA [Identifier] in specimen by Sequencing
Influenza virus A hemagglutinin segment sequence identifier
Influenza virus A hemagglutinin type RNA [Identifier] in Isolate by NAA with probe detection
Influenza virus A hemagglutinin type RNA [Identifier] in Isolate by Sequencing
Influenza virus A hemagglutinin type RNA [Identifier] in specimen by NAA with probe detection
Influenza virus A Hong Kong Ab [Units/volume] in Serum
Influenza virus A Hong Kong Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A identified in specimen by Bioassay
Influenza virus A IgA Ab [Mass/volume] in Cerebral spinal fluid
Influenza virus A IgA Ab [Presence] in Serum
Influenza virus A IgA Ab [Units/volume] in Serum by Immunoassay
Influenza virus A IgG Ab [Mass/volume] in Cerebral spinal fluid
Influenza virus A IgG Ab [Presence] in Serum
Influenza virus A IgG Ab [Presence] in Serum by Immunoassay
Influenza virus A IgG Ab [Titer] in Serum
Influenza virus A IgG Ab [Units/volume] in Serum
Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay
Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen
Influenza virus A IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Influenza virus A IgM Ab [Mass/volume] in Cerebral spinal fluid
Influenza virus A IgM Ab [Presence] in Serum
Influenza virus A IgM Ab [Presence] in Serum by Immunoassay
Influenza virus A IgM Ab [Titer] in Serum
Influenza virus A IgM Ab [Units/volume] in Serum
Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay
Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen
Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Influenza virus A Leningrad Ab [Units/volume] in Serum
Influenza virus A Leningrad Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A M gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A M gene [Presence] in Nasopharynx by NAA with probe detection
Influenza virus A matrix protein RNA [Presence] in Isolate by Sequencing
Influenza virus A matrix protein segment sequence identifier
Influenza virus A Mississippi Ab [Units/volume] in Serum
Influenza virus A Mississippi Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A N1 Ab [Presence] in Serum
Influenza virus A N1 Ab [Presence] in Serum by Neutralization test
Influenza virus A N1 RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection
Influenza virus A N2 Ab [Presence] in Serum
Influenza virus A N2 Ab [Presence] in Serum by Neutralization test
Influenza virus A N2 RNA [Cycle Threshold #] in specimen by NAA with probe detection
Influenza virus A N3 Ab [Presence] in Serum
Influenza virus A N3 Ab [Presence] in Serum by Neutralization test
Influenza virus A N4 Ab [Presence] in Serum
Influenza virus A N4 Ab [Presence] in Serum by Neutralization test
Influenza virus A N5 Ab [Presence] in Serum
Influenza virus A N5 Ab [Presence] in Serum by Neutralization test
Influenza virus A N6 Ab [Presence] in Serum
Influenza virus A N6 Ab [Presence] in Serum by Neutralization test
Influenza virus A N7 Ab [Presence] in Serum
Influenza virus A N7 Ab [Presence] in Serum by Neutralization test
Influenza virus A N8 Ab [Presence] in Serum
Influenza virus A N8 Ab [Presence] in Serum by Neutralization test
Influenza virus A N9 Ab [Presence] in Serum
Influenza virus A N9 Ab [Presence] in Serum by Neutralization test
Influenza virus A NA gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A neuraminidase cDNA [Identifier] in specimen by NAA with probe detection
Influenza virus A neuraminidase RNA [Identifier] in Isolate by NAA with probe detection
Influenza virus A neuraminidase RNA [Type] in specimen by Sequencing
Influenza virus A neuraminidase segment sequence identifier
Influenza virus A non-structural protein RNA [Presence] in Isolate by Sequencing
Influenza virus A NP gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A NS1 gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A nucleoprotein RNA [Presence] in Isolate by Sequencing
Influenza virus A PA gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A PB1 gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A PB2 gene [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A Phillipines Ab [Units/volume] in Serum
Influenza virus A Phillipines Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A polymerase A RNA [Presence] in Isolate by Sequencing
Influenza virus A polymerase B1 cDNA [Presence] in Isolate by Sequencing
Influenza virus A polymerase B2 RNA [Presence] in Isolate by Sequencing
Influenza virus A polymerase RNA [Identifier] in Isolate by Sequencing
Influenza virus A Port Chalmers Ab [Units/volume] in Serum
Influenza virus A Port Chalmers Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection
Influenza virus A RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
Influenza virus A RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection
Influenza virus A RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Influenza virus A RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Influenza virus A RNA [Presence] in Isolate by NAA with probe detection
Influenza virus A RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Influenza virus A RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Influenza virus A RNA [Presence] in Nasopharynx by NAA with non-probe detection
Influenza virus A RNA [Presence] in Nasopharynx by NAA with probe detection
Influenza virus A RNA [Presence] in Pericardial fluid by NAA with probe detection
Influenza virus A RNA [Presence] in Respiratory specimen by NAA with probe detection
Influenza virus A RNA [Presence] in Tissue by NAA with probe detection
Influenza virus A RNA [Presence] in specimen by NAA with probe detection
Influenza virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Influenza virus A RNA [Units/volume] (viral load) in specimen by NAA with probe detection
Influenza virus A RNA TCID50 [#/volume] in specimen
Influenza virus A subtype [Identifier] in Cornea or Conjunctiva by NAA with probe detection
Influenza virus A subtype [Identifier] in Lower respiratory specimen by NAA with probe detection
Influenza virus A subtype [Identifier] in specimen by Immune diffusion (ID)
Influenza virus A subtype [Identifier] in specimen by NAA with probe detection
Influenza virus A subtype [Identifier] in Upper respiratory specimen by NAA with probe detection
Influenza virus A swine origin RNA [Cycle Threshold #] in specimen by NAA with probe detection
Influenza virus A swine origin RNA [Identifier] in specimen by NAA with probe detection
Influenza virus A swine origin RNA [Presence] in specimen by NAA with probe detection
Influenza virus A Texas Ab [Units/volume] in Serum
Influenza virus A Texas Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A Victoria Ab [Units/volume] in Serum
Influenza virus A Victoria Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus A whole genome [Nucleotide sequence] in Isolate by Sequencing
Influenza virus A.adamantane resistance [Presence]
Influenza virus A.adamantane resistance [Presence] by Phenotype method
Influenza virus A.adamantane resistant RNA [Presence] by NAA with probe detection
Influenza virus A.neuraminidase inhibitor resistance [Susceptibility] Qualitative by Phenotype method
Influenza virus A+B Ab [Presence] in Body fluid
Influenza virus A+B Ab [Presence] in Serum
Influenza virus A+B Ab [Titer] in Serum by Complement fixation
Influenza virus A+B Ab [Titer] in Serum by Immunofluorescence
Influenza virus A+B Ab [Units/volume] in Serum
Influenza virus A+B Ab [Units/volume] in Serum by Immunofluorescence
Influenza virus A+B Ag [Presence] in Bronchial specimen
Influenza virus A+B Ag [Presence] in Nasopharynx
Influenza virus A+B Ag [Presence] in Nose
Influenza virus A+B Ag [Presence] in Nose by Rapid immunoassay
Influenza virus A+B Ag [Presence] in Throat
Influenza virus A+B Ag [Presence] in Throat by Immunoassay
Influenza virus A+B Ag [Presence] in Throat by Immunofluorescence
Influenza virus A+B Ag [Presence] in specimen
Influenza virus A+B Ag [Presence] in specimen by Immunoassay
Influenza virus A+B Ag [Presence] in specimen by Immunofluorescence
Influenza virus A+B RNA [Presence] in specimen by NAA with probe detection
Influenza virus A+B.neuraminidase inhibitor resistance [Susceptibility] in specimen by Genotype method
Influenza virus A+B+C Ag [Presence] in Throat
Influenza virus A+B+C Ag [Presence] in Throat by Immunoassay
Influenza virus A+B+C Ag [Presence] in Throat by Immunofluorescence
Influenza virus A+B+C Ag [Presence] in specimen
Influenza virus A+B+C Ag [Presence] in specimen by Immunoassay
Influenza virus A+B+C Ag [Presence] in specimen by Immunofluorescence
Influenza virus Ab [Units/volume] in Cerebral spinal fluid
Influenza virus Ag [Presence] in specimen
Influenza virus B [Presence] in specimen by Organism specific culture
Influenza virus B Ab [Presence] in Body fluid
Influenza virus B Ab [Presence] in Serum
Influenza virus B Ab [Presence] in Serum by Complement fixation
Influenza virus B Ab [Presence] in Serum by Immunoassay
Influenza virus B Ab [Titer] in Cerebral spinal fluid
Influenza virus B Ab [Titer] in Serum --1st specimen
Influenza virus B Ab [Titer] in Serum --2nd specimen
Influenza virus B Ab [Titer] in Serum by Complement fixation
Influenza virus B Ab [Titer] in Serum by Complement fixation --1st specimen
Influenza virus B Ab [Titer] in Serum by Complement fixation --2nd specimen
Influenza virus B Ab [Titer] in Serum by Hemagglutination inhibition
Influenza virus B Ab [Units/volume] in Cerebral spinal fluid
Influenza virus B Ab [Units/volume] in Serum
Influenza virus B Ab [Units/volume] in Serum by Complement fixation
Influenza virus B Ab [Units/volume] in Serum by Hemagglutination inhibition
Influenza virus B Ab [Units/volume] in Unspecified specimen
Influenza virus B Ag [Presence] in Bronchial specimen
Influenza virus B Ag [Presence] in Bronchial specimen by Immunofluorescence
Influenza virus B Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence
Influenza virus B Ag [Presence] in Isolate
Influenza virus B Ag [Presence] in Isolate by Immunofluorescence
Influenza virus B Ag [Presence] in Lower respiratory specimen by Immunofluorescence
Influenza virus B Ag [Presence] in Nasopharynx
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
Influenza virus B Ag [Presence] in Nasopharynx by Immunofluorescence
Influenza virus B Ag [Presence] in Nasopharynx by Rapid immunoassay
Influenza virus B Ag [Presence] in Nose by Immunoassay
Influenza virus B Ag [Presence] in Nose by Immunofluorescence
Influenza virus B Ag [Presence] in Throat
Influenza virus B Ag [Presence] in Throat by Immunoassay
Influenza virus B Ag [Presence] in Throat by Immunofluorescence
Influenza virus B Ag [Presence] in Tissue by Immunofluorescence
Influenza virus B Ag [Presence] in Trachea by Immunofluorescence
Influenza virus B Ag [Presence] in specimen
Influenza virus B Ag [Presence] in specimen by Immunoassay
Influenza virus B Ag [Presence] in specimen by Immunofluorescence
Influenza virus B IgA Ab [Mass/volume] in Cerebral spinal fluid
Influenza virus B IgA Ab [Presence] in Serum
Influenza virus B IgA Ab [Units/volume] in Serum by Immunoassay
Influenza virus B IgG Ab [Mass/volume] in Cerebral spinal fluid
Influenza virus B IgG Ab [Presence] in Serum
Influenza virus B IgG Ab [Presence] in Serum by Immunoassay
Influenza virus B IgG Ab [Titer] in Serum
Influenza virus B IgG Ab [Units/volume] in Serum
Influenza virus B IgG Ab [Units/volume] in Serum by Immunoassay
Influenza virus B IgM Ab [Mass/volume] in Cerebral spinal fluid
Influenza virus B IgM Ab [Presence] in Serum
Influenza virus B IgM Ab [Presence] in Serum by Immunoassay
Influenza virus B IgM Ab [Titer] in Serum
Influenza virus B IgM Ab [Units/volume] in Serum
Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay
Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay --1st specimen
Influenza virus B IgM Ab [Units/volume] in Serum by Immunoassay --2nd specimen
Influenza virus B lineage RNA [Identifier] in specimen by NAA with probe detection
Influenza virus B NS gene [Presence] in Nasopharynx by NAA with probe detection
Influenza virus B RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection
Influenza virus B RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
Influenza virus B RNA [Cycle Threshold #] in specimen by NAA with probe detection
Influenza virus B RNA [Identifier] in Isolate by Sequencing
Influenza virus B RNA [Presence] in Bronchoalveolar lavage by NAA with probe detection
Influenza virus B RNA [Presence] in Cerebral spinal fluid by NAA with probe detection
Influenza virus B RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
Influenza virus B RNA [Presence] in Isolate by NAA with probe detection
Influenza virus B RNA [Presence] in Lower respiratory specimen by NAA with non-probe detection
Influenza virus B RNA [Presence] in Lower respiratory specimen by NAA with probe detection
Influenza virus B RNA [Presence] in Nasopharynx by NAA with non-probe detection
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
Influenza virus B RNA [Presence] in Pericardial fluid by NAA with probe detection
Influenza virus B RNA [Presence] in Respiratory specimen by NAA with probe detection
Influenza virus B RNA [Presence] in Tissue by NAA with probe detection
Influenza virus B RNA [Presence] in specimen by NAA with probe detection
Influenza virus B RNA [Presence] in Upper respiratory specimen by NAA with probe detection
Influenza virus B Victoria and Yamagata lineage RNA panel - specimen
Influenza virus B Victoria lineage Ag [Presence] in Isolate by Hemagglutination inhibition
Influenza virus B Victoria lineage RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
Influenza virus B Victoria lineage RNA [Presence] in specimen by NAA with probe detection
Influenza virus B Yamagata lineage Ag [Presence] in Isolate by Hemagglutination inhibition
Influenza virus B Yamagata lineage Ag [Titer] in Isolate by Hemagglutination inhibition
Influenza virus B Yamagata lineage RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection
Influenza virus B Yamagata lineage RNA [Presence] in specimen by NAA with probe detection
Influenza virus C Ab [Presence] in Serum
Influenza virus C Ab [Presence] in Serum by Complement fixation
Influenza virus C Ab [Titer] in Serum by Complement fixation
Influenza virus C Ab [Units/volume] in Serum
Influenza virus C Ag [Presence] in specimen
Influenza virus C Ag [Presence] in specimen by Immunofluorescence
Influenza virus C RNA [Presence] in Isolate by NAA with probe detection
Influenza virus C RNA [Presence] in specimen by NAA with probe detection
Influenza virus D PB2 gene [Cycle Threshold #] in specimen by NAA with probe detection
Influenza virus D RNA [Cycle Threshold #] in specimen by NAA with probe detection
Influenza virus identified in Cornea or Conjunctiva by Organism specific culture
Influenza virus identified in Lower respiratory specimen by Organism specific culture
Influenza virus identified in Sputum by Organism specific culture
Influenza virus identified in Sputum tracheal aspirate by Organism specific culture
Influenza virus identified in Throat by Organism specific culture
Influenza virus identified in specimen by Organism specific culture
Influenza virus identified in specimen by Shell vial culture
Influenza virus identified in Upper respiratory specimen by Organism specific culture
Influenza virus RNA [Identifier] in specimen by Probe
Influenza virus types A and B and subtypes panel - Respiratory specimen by NAA with probe detection
Influenza virus types A and B panel - Cerebral spinal fluid by NAA with probe detection
Influenza virus types A and B panel - Cornea or Conjunctiva by NAA with probe detection
Influenza virus types A and B panel - Lower respiratory specimen by NAA with probe detection
Influenza virus types A and B panel - Tissue by NAA with probe detection
Influenza virus types A and B panel - Upper respiratory specimen by NAA with probe detection
Influenza virus.neuraminidase inhibitor resistance [Susceptibility] by Genotype method
Influenza virus.neuraminidase inhibitor resistance [Susceptibility] Qualitative
Swine influenza virus Ab [Presence] in Serum
Swine influenza virus Ab [Presence] in Serum by Hemagglutination inhibition
Swine influenza virus Ag [Presence] in Tissue by Immune stain
Swine influenza virus Ag [Presence] in Tissue by Immunofluorescence
Influenza virus A avian origin nucleoprotein Ab/Negative control in Serum by Immunoassay
Influenza virus A H1 2009 pandemic RNA [Presence] in Throat by NAA with non-probe detection
Influenza virus A H1 RNA [Presence] in Respiratory specimen by NAA with probe detection
Influenza virus A H3 RNA [Presence] in Respiratory specimen by NAA with probe detection
Influenza virus A RNA [Presence] in Throat by NAA with non-probe detection
Influenza virus A H3 RNA [Presence] in Throat by NAA with non-probe detection
Influenza virus A RNA [Presence] in Nose by NAA with non-probe detection
Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
Influenza virus A N1 RNA [Presence] in Specimen by NAA with probe detection
Influenza virus B RNA [Presence] in Nose by NAA with non-probe detection
Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
Influenza virus B RNA [Presence] in Throat by NAA with non-probe detection
Influenza virus A H7 Eurasia RNA [Presence] in Specimen by NAA with probe detection
Influenza virus types A and B and subtypes RNA panel - Specimen by NAA with probe detection
Respiratory pathogens panel - Throat by Immunofluorescence
Respiratory pathogens panel - Bronchoalveolar lavage by Immunofluorescence
Respiratory pathogens panel - Nasopharynx by Immunofluorescence
Respiratory pathogens panel - Specimen by Organism specific culture
Respiratory pathogens DNA and RNA 12a panel - Specimen by NAA with probe detection
Respiratory pathogens DNA and RNA 12b panel - Specimen by NAA with probe detection
Respiratory syncytial virus Ab.IgG & IgM panel
Respiratory syncytial virus A 5' UTR RNA
Respiratory syncytial virus Ab^1st specimen
Respiratory syncytial virus Ab^2nd specimen
Human metapneumovirus & Respiratory syncytial virus RNA panel
SARS coronavirus 2 & Respiratory syncytial virus Ag
Cells.CD4+CD154+/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide
Cells.CD4+CD154+/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide
Cells.CD4.Interferon gamma-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide
Cells.CD4.Interferon gamma-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide
Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide
Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide
Percent neutralization by SARS coronavirus 2 spike protein RBD Ab.neut
SARS coronavirus 2 spike & nucleocapsid protein stimulated gamma interferon panel
SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells^^corrected for background
SARS coronavirus 2 stimulated gamma interferon release by lymphocytes^^corrected for background
SARS coronavirus 2 stimulated gamma interferon release by T-cells.Nucleocapsid Ag spot count^^corrected for background
SARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count^^corrected for background
SARS coronavirus 2 & SARS-related coronavirus RNA panel
SARS coronavirus 2 Mpro gene mutation detected
SARS coronavirus 2 nucleocapsid protein Ab.IgG
SARS coronavirus 2 RdRp gene mutation detected
SARS coronavirus 2 S gene mutation detected
SARS coronavirus 2 spike protein RBD Ab.neut
SARS coronavirus 2 sequencing & identification panel
SARS coronavirus 2 specific TCRB gene rearrangements
SARS coronavirus 2 variant interpretation
SARS coronavirus 2 stimulated gamma interferon
SARS coronavirus 2 stimulated gamma interferon panel
SARS coronavirus 2 stimulated gamma interferon release by T-cells^^corrected for background
SARS coronavirus 2 stimulated gamma interferon release by T-cells
SARS-related coronavirus+MERS coronavirus RNA
Volatile Organic Compounds associated with SARS-CoV-2 infection
Influenza virus A and B Ag panel � Upper Respiratory specimen by Rapid immunoassay
Influenza virus A and Influenza virus B and SARS coronavirus 2 RNA panel - Nose by NAA with non-probe detection
Infectious agent antigen detection by immunofluorescent technique; respiratory syncytial virus
Infectious agent detection by nucleic acid (DNA or RNA); respiratory syncytial virus, amplified probe technique
Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique
Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when perfor
Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique
Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique
Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; respiratory syncytial virus
Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; respiratory syncy
Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen
Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])
Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]); screen
Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]); titer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) antibody, quantitative
Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])
Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), includes titer(s), when performed
Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), ELISA, plasma, serum
Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen rep
Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), amplified probe technique, including multiplex reverse transcription for
Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identification in targeted region(s)
Detection of SARS-CoV-2, Influenza A and Influenza B
Influenza A and B Antibodies, Quantitative
Infectious agent antigen detection by immunofluorescence technique, Influenza B
Infectious agent antigen detection by immunofluorescence technique, Influenza A
Infectious agent antigen detection by enzyme immunoassay technique, qualitative or semiquantitative, multiple-step method; Influenza, A or B, each
Determine the presence of influenza virus through nucleic acid detection including reverse transcription and amplified probe technique for each type or subtype
Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-types
Presence of influenza virus through nucleic acid detection including multiplex amplified probe technique and possibly multiplex reverse transcription for each additional influenza virus type or subtype after the detection of the first two types or subtypes
Infectious agent antigen detection by immunoassay with direct optical observation; influenza
Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; severe acute resp
Infectious agent antigen detection by immunofluorescent technique; not otherwise specified, each organism
Infectious agent antigen detection by immunofluorescent technique, polyvalent for multiple organisms, each polyvalent antiserum
ePlex� Respiratory Pathogen (RP) Panel (ePlex RP� panel) from GenMark Diagnostics, Inc., which is an automated molecular multiplexed nucleic acid diagnostic test on a nasopharyngeal specimen collected obtained from patients suspected of respiratory tract infections for a total of 20 (2 bacterial and 18 viral) common viral and bacterial respiratory pathogens.
Virus isolation; tissue culture, additional studies or definitive identification (eg, hemabsorption, neutralization, immunofluorescence stain), each isolate
Immunoassay for infectious agent antibody(ies) and to be a parent to 86328
Viral Culture, General; Virus isolation; tissue culture inoculation, observation, and presumptive identification by cytopathic effect